Follow
Назарій Кобиляк
Назарій Кобиляк
Bogomolets National Medical University, department endocrinology
Verified email at nmu.kiev.ua
Title
Cited by
Cited by
Year
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ...
Jama 321 (1), 69-79, 2019
10752019
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, ...
New England journal of medicine 385 (10), 896-907, 2021
4132021
Probiotics in prevention and treatment of obesity: a critical view
N Kobyliak, C Conte, G Cammarota, AP Haley, I Styriak, L Gaspar, ...
Nutrition & metabolism 13, 1-13, 2016
3792016
Triglyceride lowering with pemafibrate to reduce cardiovascular risk
A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ...
New England Journal of Medicine 387 (21), 1923-1934, 2022
3222022
A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial
N Kobyliak, L Abenavoli, G Mykhalchyshyn, L Kononenko, L Boccuto, ...
2062018
Pathophysiological role of host microbiota in the development of obesity
N Kobyliak, O Virchenko, T Falalyeyeva
Nutrition journal 15, 1-12, 2015
1792015
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial
N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ...
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018
1782018
Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA
DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ...
Circulation 139 (3), 351-361, 2019
1652019
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1612022
Caffeine and cardiovascular diseases: critical review of current research
A Zulli, RM Smith, P Kubatka, J Novak, Y Uehara, H Loftus, T Qaradakhi, ...
European Journal of Nutrition, 1-13, 2016
1092016
Probiotics function and modulation of the immune system in allergic diseases
M Eslami, A Bahar, M Keikha, M Karbalaei, NM Kobyliak, B Yousefi
Allergologia et Immunopathologia 48 (6), 771-788, 2020
962020
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3
L Abenavoli, M Masarone, V Peta, N Milic, N Kobyliak, S Rouabhia, ...
World journal of gastroenterology: WJG 20 (41), 15233, 2014
882014
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a …
J Rosenstock, V Perkovic, JH Alexander, ME Cooper, N Marx, MJ Pencina, ...
Cardiovascular diabetology 17, 1-15, 2018
872018
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ...
872018
Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease
L Abenavoli, T Falalyeyeva, L Boccuto, O Tsyryuk, N Kobyliak
Pharmaceuticals 11 (4), 104, 2018
792018
Crosstalk between gut microbiota and antidiabetic drug action
Y Kyriachenko, T Falalyeyeva, O Korotkyi, N Molochek, N Kobyliak
World journal of diabetes 10 (3), 154, 2019
732019
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult …
O Savcheniuk, N Kobyliak, M Kondro, O Virchenko, T Falalyeyeva, ...
BMC complementary and alternative medicine 14, 1-17, 2014
702014
Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative …
NM Kobyliak, TM Falalyeyeva, OG Kuryk, TV Beregova, PM Bodnar, ...
EPMA Journal 6, 1-22, 2015
682015
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
N Kobyliak, O Virchenko, T Falalyeyeva, M Kondro, T Beregova, P Bodnar, ...
Biomedicine & Pharmacotherapy 90, 608-614, 2017
672017
Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial
GJ Biessels, C Verhagen, J Janssen, E van den Berg, B Zinman, ...
Diabetes care 42 (10), 1930-1938, 2019
662019
The system can't perform the operation now. Try again later.
Articles 1–20